Home
>
National Drug Code (NDC)
>
DDAVP
DDAVP - 0075-0026-00 - (Desmopressin Acetate)
Drug Information of DDAVP
| Product NDC: | 0075-0026 |
| Proprietary Name: | DDAVP |
| Non Proprietary Name: | Desmopressin Acetate |
| Active Ingredient(s): | .2 mg/1 & nbsp; Desmopressin Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DDAVP
| Product NDC: | 0075-0026 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019955 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950906 |
Package Information of DDAVP
| Package NDC: | 0075-0026-00 |
| Package Description: | 100 TABLET in 1 BOTTLE (0075-0026-00) |
NDC Information of DDAVP
| NDC Code | 0075-0026-00 |
| Proprietary Name | DDAVP |
| Package Description | 100 TABLET in 1 BOTTLE (0075-0026-00) |
| Product NDC | 0075-0026 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desmopressin Acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19950906 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | .2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |
